is invokana a glp-1 The Role of GLP-1, DPP-4, and SGLT-2 Inhibitors in Diabetes Management Are GLP-1s and SGLT2s replacements
Description
Wegovy is specifically designed to reduce appetite and promote weight loss, whilst bupropion is generally considered weight-neutral or may cause modest weight loss
Were not really seeing it in diabetes
Take the 5-minute screening
These biologic approaches are more difficult and expensive to manufacture and arent amenable to oral delivery
